In this study, two different genetic therapies were made using virus (AAV9) to deliver gene editing CRISPR guides to the heart. The work showed significant potential for a single dose to correct the genetic misspellings which cause hypertrophic cardiomyopathy (HCM), a disorder that increases risk of sudden cardiac death and affects around 1 in 500 people. Read the full paper here.
